Primary cutaneous angiosarcoma is a rare vasoformative malignant neoplasm that can present a diagnostic and therapeutic challenge. We describe a 76-year-old Caucasian man with right upper eyelid swelling and nodularity, initially suspected clinically to represent either ocular adnexal lymphoma or basal cell carcinoma. Incisional biopsy and wide resection of the mass with frozen section control of margins were interpreted as compatible with hobnail (Dabska-retiform) hemangioendothelioma. Foci of atypia were noted in the tumor, raising speculation of evolution into a more aggressive neoplasm, such as conventional angiosarcoma. The patient subsequently underwent two additional wide resections with frozen section control of margins in an attempt to obtain complete excision of residual tumor, which demonstrated histopathologic features favoring angiosarcoma. The histologic material from the original and subsequent resections was sent in consultation to several soft tissue pathology experts and the final diagnosis of low-grade cutaneous angiosarcoma was established. Despite repeated surgical interventions, there was continued persistence of the tumor in the deep orbital tissues. Various management options, including adjuvant radiotherapy/chemotherapy with and without orbital exenteration, were discussed. The patient decided against further surgical intervention and is currently undergoing adjuvant radiotherapy/chemotherapy. This case illustrates the diagnostic and management difficulties of ocular adnexal angiosarcoma.

Keywords:
Eye, Eyelid, Tumor, Angiosarcoma, Hemangioendothelioma, Hobnail hemangioendothelioma, Retiform hemangioendothelioma
1.
Goldblum JR, Folpe AL, Weiss SW: Malignant vascular tumors; in Goldblum JR, Folpe AL, and Weiss SW (eds): Enzinger and Weiss' Soft Tissue Tumors, 6th ed. Philadelphia, Elsevier Saunders, 2014, pp 703-723.
2.
Demirci H, Christanson MD: Eyelid angiosarcoma: a case report and review of the literature. Middle East Afr J Ophthalmol 2013;20:259-262.
3.
Hamill EB, Agrawal M, Diwan AH, Winthrop KL, Marx DP: Angiosarcoma of the eyelid with superimposed enterobacter infection. Ophthal Plast Reconstr Surg 2016;32:e59-e60.
4.
Lemanski N, Farber M, Carruth BP, Wladis EJ: Primary adnexal angiosarcoma masquerading as periorbital hematoma. Surv Ophthalmol 2014;59:655-659.
5.
Cox CA, Wein RO, Ghafouri R, Laver NM, Heher KL, Kapadia MK: Angiosarcoma presenting with minor erythema and swelling. Case Rep Ophthalmol 2013;4:59-63.
6.
Pontes AB, Ucelli JLR, Obadia DL, Nascimento LVD: Exuberant angiosarcoma. An Bras Dermatol 2017;92:287-289.
7.
Ambujam S, Audhya M, Reddy A, Roy S: Cutaneous angiosarcoma of the head, neck, and face of the elderly in type 5 skin. J Cutan Aesthet Surg 2013;6:45-47.
8.
Papalas JA, Manavi CK, Woodward JA, Sangueza OP, Cummings TJ: Angiosarcoma of the eyelid: a clinicopathologic comparison between isolated unilateral tumors and tumors demonstrating extrapalpebral involvement. Am J Dermatopathol 2010;32:694-699.
9.
DeMartelaere SL, Roberts D, Burgess MA, Morrison WH, Pisters PW, Sturgis EM, Ho V, Esmaeli B: Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement. Head Neck 2008;30:639-646.
10.
Gündüz K, Shields JA, Shields CL, Eagle RC Jr, Nathan F: Cutaneous angiosarcoma with eyelid involvement. Am J Ophthalmol 1998;6:870-871.
11.
Calonje JE and Fletcher CDM: Vascular tumors; in Fletcher CDM (ed): Diagnostic Histopathology of Tumors, 4th ed. Philadelphia, Elsevier Saunders, 2013, vol 1, pp 42-91.
12.
Al-Faky YH, Al-Mosallam AR, Al-Rikabi AC, Al-Sohaibani MO: Medial canthus retiform hemangioendothelioma. Indian J Ophthalmol 2014:491-493.
13.
Ito T, Uchi H, Nakahara T, Tsuji G, Oda Y, Hagihara A, Furue M: Cutaneous angiosarcoma of the head and face: a single-center analysis of treatment outcomes in 43 patients in Japan. J Cancer Res Clin Oncol 2016;142:1387-1394.
14.
Barttelbort SW, Stahl R, Ariyan S: Cutaneous angiosarcoma of the face and scalp. Plast Reconstr Surg 1989;84:55-59.
15.
de Keizer RJ, de Wolff-Rouendaal D, Nooy MA: Angiosarcoma of the eyelid and periorbital region. Experience in Leiden with iridium192 brachytherapy and low-dose doxorubicin chemotherapy. Orbit 2008;27:5-12.
16.
Miura H, Asada Y: Treatment of eyelid lesion of angiosarcoma with facial artery recombinant interleukin-2 (rIL-2) injection. J Am Acad Dermatol 2006;54:907-908.
17.
Shustef E, Kazlouskaya V, Prieto VG, Ivan D, Aung PP: Cutaneous angiosarcoma: a current update. J Clin Pathol 2017;70:917-925.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.